Sanofi
- Market cap
- 96.32B
- P/E (TTM)i
- 21.97
- P/Bi
- 1.24
- EPSi
- 3.57
- Div yieldi
- 5.88%
- 52W posi
- 10%
Anonymous reader poll. Unscientific, not investment advice.
Sanofi last traded at 40.20, up 1.62% on the session. The company carries a market value of roughly 96.32B, the #211 most valuable US-listed company we track. Trading at a P/E of 21.53, the stock is 22% above its own five-year norm of 17.67. It pays a dividend yielding 5.88% on a trailing basis. Wall Street's 3-analyst consensus lands on Hold, with a price target averaging 53.00 (+32% from here). The shares sit 10% of the way up their 52-week range of 39.18 to 49.91.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 7 months.
- Recent price momentum is -10.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Hold.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 21.5x | Better than 43% |
| Forward P/E | 11.0x | Better than 79% |
| Price / Sales | 1.8x | Better than 66% |
| P/E vs own 5-yr range | 81st pctl | Better than 26% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 4.8% | Better than 43% |
| Net income CAGR (3Y) | -2.3% | Better than 34% |
| Free cash flow CAGR (3Y) | -5.0% | Better than 28% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 72.1% | Better than 85% |
| Operating margin | 20.5% | Better than 67% |
| Net margin | 16.7% | Better than 67% |
| Return on equity | 10.5% | Better than 40% |
| Return on invested capital | 8.6% | Better than 49% |
Momentum C-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -8.1% | Better than 33% |
| 6-month return | -11.0% | Better than 21% |
| 12-month return (ex latest month) | -6.1% | Better than 25% |
| Distance below 52-week high | 20.8% | Better than 45% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.1x | Better than 31% |
| Debt to assets | 28.5% | Better than 51% |
| Interest coverage | 10.9x | Better than 66% |
| Free cash flow / net income | 92.3% | Better than 34% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 0.0% | Better than 0% |
| Upside to average target | 34.1% | Better than 67% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 39.56
- Open
- 39.94
- Day range
- 39.72 - 40.25
- Avg price
- 40.07
- Volume
- 2.08M
- Turnover
- 83.41M
- Turnover ratei
- 0.10%
- Volume ratioi
- 0.47
- Amplitudei
- 1.34%
- 52-week rangei
- 39.18 - 49.91
Valuation
- P/Ei
- 11.27
- P/E (TTM)i
- 21.97
- P/Bi
- 1.24
- EPSi
- 3.57
- Book value / shi
- 32.34
- Net profit
- 8.54B
- Net assets
- 77.48B
Share structure
- Market cap
- 96.32B
- Float capi
- 86.84B
- Shares out
- 2.40B
- Float sharesi
- 2.16B
Dividend & listing
- Div yield (TTM)i
- 5.88%
- Dividend (TTM)
- 2.37
- Listing date
- 1970-01-01
19.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-26.31M net over the window
Short interest
- Shares short
- 9.30M
- % of floati
- 0.39%
- Days to coveri
- 4.30
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Sanofi (SNY)?
Sanofi last traded at 40.20. The quote on this page refreshes every few seconds while US markets are open.
What is Sanofi's market cap?
About 96.32B.
What is the P/E ratio of Sanofi?
The trailing twelve-month P/E is 21.97, above its own 5-year average of 17.67 — toward the top of its historical range (77.49% percentile). See the Valuation tab for the full history.
Does Sanofi pay a dividend?
Yes. The trailing dividend yield is 5.88%. The 2025 payout was up 7.8% from 2024. See the Dividends tab for the full payment history.
Is Sanofi a buy according to analysts?
The consensus of 3 analysts is a Hold rating, with an average 12-month price target of 53.00, which implies 31.8% upside from the current price. This is not investment advice.
What is Sanofi's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Sanofi a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 07:37:17 · For reference only, not investment advice and not tailored to your situation.